Panic attack nasal spray trial pulled before it began
Symptom relief
Terminated
This study aimed to test a nasal spray containing dexmedetomidine for quickly relieving panic attacks in adults. Panic attacks affect about 13% of adults, and current fast-acting treatments can be addictive. The spray was designed to work within minutes. However, the trial was wi…
Phase: NA • Sponsor: Tongji University • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC